ESCRS - Ab interno trabeculectomy ;
ESCRS - Ab interno trabeculectomy ;

Ab interno trabeculectomy

Removal of trabecular tissue with small-gauge vitreous cutter effective in lowering IOP

Ab interno trabeculectomy
Roibeard O’hEineachain
Roibeard O’hEineachain
Published: Tuesday, February 28, 2017
      Adrian Gavanescu MD Adrian Gavanescu MD Early results with an ab interno trabeculectomy technique performed with a 23-gauge vitreous cutter under gonioscopic view can produce substantial intraocular pressure (IOP) reductions in patients with open-angle glaucoma, according to Adrian Gavanescu MD, of Clinical Hospital Nicolae Malaxa, Bucharest, Romania. “This is an internal filtering procedure involving the excision of trabecular meshwork tissue and leaving a large distance between edges to prevent scarring and fibrosis,” said Dr Gavanescu in a poster presentation at the XXXIV Congress of the ESCRS in Copenhagen, Denmark. He presented the results achieved in 17 open-angle glaucoma patients who underwent the ab interno trabeculectomy procedure, with or without cataract surgery. In the five patients who underwent the procedure in combination with cataract surgery, the mean IOP at six months follow-up was 13.5mmHg. That compared to 21.6mmHg preoperatively and amounted to a 37.5% reduction. Among those who underwent ab interno trabeculectomy alone, the mean IOP was 14.5mmHg at six months. That compared to 26mmHg preoperatively and amounted to a 44.24% reduction. In addition, all patients were able to maintain their low pressures throughout follow-up without further use of IOP-lowering medications. The only postoperative complication was hyphaema which occurred in two patients but disappeared within eight to 10 days. SURGICAL STEPS The selective ab interno trabeculectomy procedure begins with the creation of two 1.0mm near-limbal corneal incisions with a 20-G lance knife, one at 2 o’clock for the anterior chamber maintainer and the other at 10 o’ clock for insertion of the vitreous cutter. A miotic agent is then used to obtain better access to the angle. The next step is to visualise the trabecular meshwork using a goniolens. If the pigmented portion of the meshwork is still not visible, inducing hypotony will enable visualisation of Schlemm’s canal. The goniolens is then removed and the vitreous cutter inserted into the anterior chamber. The goniolens is then replaced on the cornea and the vitreous cutter’s tip is advanced until it makes contact with the trabecular meshwork.
The surgical technique has evolved since the time of the poster presentation at the XXXIV Congress of the ESCRS, from two 1mm incisions to one 2.2mm incision that can accommodate both the vitreous cutter with a special irrigator on top, to maintain the anterior chamber depth
After gently pressing the iris, the surgeon inserts the tip of the vitreous cutter into the meshwork and activates its infusion/aspiration and cutting functions to ablate an arc of 30 to 90 degrees of trabecular meshwork tissue and the inner wall of Schlemm’s canal. The patient’s postoperative regimen includes pilocarpine, one drop four times a day for two months; dexamethasone, one drop four times a day for two weeks; and netilmicine, one drop four times a day for two weeks. This new procedure was also presented at the 20th ESCRS Winter Meeting in Athens, Greece, the 12th European Glaucoma Society Congress in Prague, Czech Republic, and at DOG 2016 in Berlin, Germany. The surgical technique has evolved since the time of the poster presentation at the XXXIV Congress of the ESCRS, from two 1mm incisions to one 2.2mm incision that can accommodate both the vitreous cutter with a special irrigator on top, to maintain the anterior chamber depth. Adrian Gavanescu: gdr358@yahoo.com To view a video of this new procedure, go to: https://m.youtube.com/watch?sns=fb&list=PLJJBUkfz3mGw79Zb5py_XPW5Jg-S4JSJS&v=gBzp4A5YgpM
Tags: trabulectomy
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;